FIELD: medicine; bioengineering. SUBSTANCE: method involves producing recombinant polypeptide possessing SCCE activity by culturing mouse cells C127 transformed with expression vector containing nucleotide sequence (SEQ IDN1) encoding the polypeptide. 0.001-25% of native or recombinant SCCE is included into the pharmaceutical composition for treating disorders related to keratinization. EFFECT: improved method for producing enzyme of high activity with respect to skin cornea layer. 7 cl, 36 dwg, 5 tbl
Title |
Year |
Author |
Number |
DNA MOLECULE FOR EXPRESSION OF BILE SALT-STIMULATED LIPASE |
1996 |
|
RU2157847C2 |
ANTIGEN OF HELICOBACTER PYLORI AND VACCINE COMPOSITION |
1996 |
- Belin Ingrid
- Svennerkhol'M Ann-Mari
|
RU2195463C2 |
VARIANTS OF LIPASE STIMULATING BY BILE SALTS, DNA ENCODING THEREOF AND TRANSGENE MAMMALS NO BELONGING TO HUMANS |
1994 |
- Blekberg Lars
- Ehdlund Mikhaehl'
- Khansson Lennart
- Khernell' Olle
- Lundberg Lennart
- Stremkvist Mats
- Ternell' Jan
|
RU2219239C2 |
TRANSGENIC PLANTS EXPRESSING GENE ENCODING ACETYL-COA-CARBOXYLASE |
1996 |
- Gengenbakh Berl G.
- Somers Dehvid Eh.
- Vajs Donal'D L.
- Gronvold Dzhon V.
- Ehgli Margaret Eh.
- Luts Shejla M.
|
RU2187555C2 |
IMMUNOGENIC HYBRID POLYPEPTIDES AGAINST OBESITY AND COMPOSITION OF ANTI-OBESITY VACCINES, CONTAINING SAID POLYPEPTIDES |
2007 |
- Kim Khio Dzoon
- Li Kheedzong
|
RU2418005C2 |
POLYPEPTIDE-LIGAND FLT3 (VARIANTS), POLYNUCLEOTIDE (VARIANTS), EXPRESSING VECTOR (VARIANTS), STRAIN OF CELL CHO (VARIANTS), METHOD FOR PRODUCING POLYPEPTIDE-LIGAND FLT3 (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS) |
1994 |
- Lajmehn Stjuart D.
- Bekmann M. Patritsija
|
RU2220979C2 |
DNA FRAGMENT ENCODING IMMUNOGENIC SURFACE MEROSOITE POLYPEPTIDE, IMMUNOGENIC POLYPEPTIDE (VARIANTS) AND A METHOD OF ITS PREPARING, RECOMBINANT PLASMID DNA AND A METHOD OF ITS PREPARING, A METHOD OF PREPARING RECOMBINANT VIRUS OF VACCINE, A METHOD OF PREPARING MICROORGANISM, VACCINE AGAINST COCCIDIOSIS IN POULTRY |
1992 |
- Mehri-Khelen Binger
- Luis Pazamontes
|
RU2130072C1 |
FUSED POLYPEPTIDE OR ITS SALT, EXPRESSING VECTOR AND PHARMACEUTICAL COMPOSITION DESIGNATED FOR TREATMENT OF IGE-MEDIATED DISEASES |
1997 |
- Digan Mehri Ehllen
- Lejk Filip
- Gram Germann
|
RU2209211C2 |
METHODS OF PURIFYING POLYPEPTIDES |
2011 |
- Lyu Khoj F.
- Kelli Brajan Devid
- Majers Dianna E.
- Makkui Bet
- Petti Krista Mari
|
RU2594163C2 |
ISOLATED NUCLEIC ACID ENCODING POLYPEPTIDE TAG 7, ISOLATED POLYPEPTIDE TAG 7, METHOD FOR INHIBITION OF TUMOR DEVELOPMENT IN MAMMALS (VARIANTS) AND METHOD FOR TREATMENT OF CANCER IN ANIMAL (VARIANTS) |
1998 |
- Georgiev Georgij
- Kiselev Sergej
- Prokhorchuk Egor
- Ostermann Ehlinborg
|
RU2238976C2 |